Filing Details
- Accession Number:
- 0000950170-23-035680
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-07-31 07:58:47
- Reporting Period:
- 2023-07-27
- Accepted Time:
- 2023-07-31 07:58:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1832415 | Better Therapeutics Inc. | BTTX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1276700 | Frank Karbe | C/O Better Therapeutics, Inc. 548 Market Street, #49404 San Francisco CA 94104 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-07-27 | 137,005 | $0.73 | 429,429 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- On July 25, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.7299 per share.
- As one of the PIPE Investors, the Reporting Person acquired 137,005 shares of Issuer common stock on July 27, 2023 for $0.7299 per share.